Start Date
March 1, 2019
Primary Completion Date
December 3, 2019
Study Completion Date
December 3, 2019
Guanfacine Extended Release
Intuniv (guanfacine) is a prescription medicine used to treat attention deficit hyperactivity disorder (ADHD) in children who are at least 6 years old. An open-label trail of guanfacine extended release (GXR 1-4 mg/daily; Intuniv™) suggested benefits in improving behavioral and emotional regulation in children and adolescents with symptoms of traumatic stress. However, to date no controlled clinical trial has been completed assessing the effects of GXR on traumatic stress symptoms in youths
Mindfulness Skills Therapy
Mindfulness is a therapy for anxiety and stress. Mindfulness forms of therapy involve regulation of attention, maintaining it in immediate experience, regardless of the valence and desirability of the experience. To reduce anxiety, Mindfulness encourages observing and accepting anxiety-related thoughts
Placebo
Placebo oral capsule
UConn Health, Farmington
Collaborators (1)
Shire
INDUSTRY
Yale University
OTHER
UConn Health
OTHER